Molecular Communication: An acid tale of prion formation
- University of Kent, United Kingdom
The transformation of grape juice into an appetising alcoholic beverage is not as straightforward as one might imagine. The yeast Saccharomyces cerevisiae is responsible for fermenting the sugars naturally found in grapes to make ethanol and carbon dioxide. Yet grapes, like many fruits, also contain L-malic acid, which has a sour taste, so the winemaker must trigger a process known as malolactic fermentation to turn the offending L-malic acid into the more palatable and ‘softer’ tasting L-lactic acid.
A variety of bacteria carry out the malolactic fermentation. Such bacteria may already be present on the skin of the grapes or the winemaker can add them after the alcoholic fermentation has taken place. Oenococcus oeni is the bacterium of choice for winemakers, partly because – unlike many other bacteria that produce lactic acid – it does not inhibit the ability of the yeast to ferment sugars.
Louis Pasteur first noted that lactic acid-producing bacteria are often associated with failed wine fermentations over 140 years ago (Pasteur, 1873; Alexandre et al., 2004). Yet, we are only now beginning to understand the complexity of the interplay between these bacteria and yeast during winemaking, thanks largely to the work of the late Susan Lindquist (who died only last month), and Daniel Jarosz, who is now at Stanford University School of Medicine. Now, in eLife, David Garcia of Stanford, David Dietrich and Jon Clardy of Harvard Medical School, and Jarosz report that lactic acid produced by certain bacteria can trigger the formation of the [GAR+] prion in fermenting yeast (Garcia et al., 2016).
Prions are made when proteins undergo a change in conformation and activity that they can sustain themselves and help other proteins to adopt. This in turn gives rise to a heritable form of the protein (known as the amyloid form) that assembles into clumps. However, unlike other yeast prions, the transmission of [GAR+] from cell to cell is not associated with a heritable amyloid. Rather, two other proteins contribute to the formation of the [GAR+] prion in yeast cells (Brown and Lindquist, 2009). But what has the [GAR+] prion got to do with lactic acid and failed wine fermentations?
The [GAR+] prion triggers a remarkable reprogramming of the carbohydrate metabolism in the host cell. By overriding an ancient mechanism that promotes the breakdown of glucose over other sources of carbon, [GAR+] cells are able to metabolise a wide range of other carbon sources, even when glucose is present (Brown and Lindquist, 2009). This is bad news for the winemaker because [GAR+] cells generate less ethanol, which aids the growth of lactic acid-producing bacteria (Figure 1).
Figure 1
Certain bacteria communicate with yeast cells via lactic acid.
L-malic acid (C4H6O5) is a natural component of grapes and other soft fruits, and it is decarboxylated by certain bacteria (red) during malolactic fermentation to produce L-lactic acid (C3H6O3) and carbon dioxide (CO2). The L-lactic acid can then induce the formation of the [GAR+] prion from the [gar-] protein in yeast cells (yellow). Cells carrying this prion (dark yellow) produce less ethanol from the fermentation of sugars, which in turn provides an environment in which the bacteria can flourish. Winemakers try to promote the production of ethanol and reduce levels of malic acid.
Earlier studies by Jarosz and Lindquist found that a wide range of bacteria secrete a chemical messenger (with a low molecular weight) that induces the appearance of [GAR+] in several different yeast species (Jarosz et al., 2014a, 2014b). Since this messenger was resistant to digestion by enzymes, researchers assumed that it was a metabolite. Garcia et al. now report that L-lactic acid can serve as this messenger.
This is not to say that L-lactic acid is the only messenger. Moreover, it is striking that a number of lactic acid-producing bacteria do not induce the [GAR+] prion. These include O. oeni (Jarosz et al., 2014b), whose inability to induce the prion may well contribute to its suitability for wine production. It has been known for over 50 years that the interactions between yeast and the bacteria involved in malolactic fermentation depend on the combinations of species present (Fornachon, 1968), and now we better understand why such variation exists.
The physical structure of the [GAR+] prion and the method by which lactic acid induces its formation remain to be established. However, the new communication mechanism discovered by Garcia et al. is important because it is beneficial to both yeast and bacteria in their native environments, and because it finally explains an observation first made by Pasteur over 140 years ago.
References
-
Saccharomyces cerevisiae-Oenococcus oeni interactions in wine: current knowledge and perspectivesInternational Journal of Food Microbiology 93:141–154.https://doi.org/10.1016/j.ijfoodmicro.2003.10.013
-
A heritable switch in carbon source utilization driven by an unusual yeast prionGenes & Development 23:2320–2332.https://doi.org/10.1101/gad.1839109
-
Influence of different yeasts on the growth of lactic acid bacteria in wineJournal of the Science of Food and Agriculture 19:374–378.https://doi.org/10.1002/jsfa.2740190705
-
BookEtudes Sure Le Vin, Ses Maladies, Causes Qui Les Provoquent Procedes Nouveau Pour Le Conserver Et Pour Le Vieillir (2nd Edition)Paris: Librairie F. Savy.
Article and author information
Author details
Publication history
Copyright
© 2016, Tuite
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,611
- views
-
- 180
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Molecular Communication: An acid tale of prion formation
eLife 5:e22256.
https://doi.org/10.7554/eLife.22256
Further reading
-
- Chromosomes and Gene Expression
- Microbiology and Infectious Disease
Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.
